HSBC's Global Capabilities for the Biopharmaceutical Industry

Mar 20, 2024

Reece Kresser, Managing Director, U.S. Biopharmaceutical Investment Banking for HSBC, describes the increasingly global nature of our industry and how HSBC can match companies with global investors.

To learn more about how HSBC can partner to help your company go global, please reach out to Reece: Reece.Kresser@us.hsbc.com.

#Sponsored

Recent Posts

See All

Tour of Scotland: Outrun Therapeutics is aiming to create a new category of therapeutics by stabilizing proteins via drugging E3 ligases

Tour of Scotland: Tay Therapeutics is a product of University of Dundee's Drug Discovery Unit, and is working on small molecules - including a topical pan-BET that is in phase 2

Tour of Scotland: University of Dundee has established a world-class Centre for Protein Degradation, one of the hottest emerging modalities in biotech

HSBC's Global Capabilities for the Biopharmaceutical Industry

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight